136 related articles for article (PubMed ID: 15948360)
1. Irritable bowel syndrome: the possible benefits of probiotics.
Isselbacher KJ
Postgrad Med; 2005 May; 117(5):7. PubMed ID: 15948360
[No Abstract] [Full Text] [Related]
2. The use of probiotics in the treatment of irritable bowel syndrome: two case reports.
Faber S; Rigden S; Lukaczer D
Altern Ther Health Med; 2005; 11(4):60-2. PubMed ID: 16053123
[No Abstract] [Full Text] [Related]
3. The use of probiotics in the treatment of irritable bowel syndrome.
Gaby AR
Altern Ther Health Med; 2006; 12(1):17; author reply 17. PubMed ID: 16454141
[No Abstract] [Full Text] [Related]
4. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
5. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.
Williams EA; Stimpson J; Wang D; Plummer S; Garaiova I; Barker ME; Corfe BM
Aliment Pharmacol Ther; 2009 Jan; 29(1):97-103. PubMed ID: 18785988
[TBL] [Abstract][Full Text] [Related]
6. Probiotics in functional bowel disorders getting it right.
Quigley EM
J Clin Gastroenterol; 2011 Jul; 45(6):481-2. PubMed ID: 21617544
[No Abstract] [Full Text] [Related]
7. Probiotics in irritable bowel syndrome: underachievers or underpowered?
Ford AC
Aliment Pharmacol Ther; 2010 Apr; 31(8):922-3; author reply 923-4. PubMed ID: 20415830
[No Abstract] [Full Text] [Related]
8. Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial.
Sadrin S; Sennoune SR; Gout B; Marque S; Moreau J; Grillasca J; Pons O; Maixent JM
Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):122-131. PubMed ID: 28980935
[TBL] [Abstract][Full Text] [Related]
9. A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial.
Sadrin S; Sennoune S; Gout B; Marque S; Moreau J; Zinoune K; Grillasca JP; Pons O; Maixent JM
Dig Liver Dis; 2020 May; 52(5):534-540. PubMed ID: 31952938
[TBL] [Abstract][Full Text] [Related]
10. Probiotics and functional gastrointestinal disorders in children.
Vandenplas Y; Benninga M
J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S107-9. PubMed ID: 19300120
[TBL] [Abstract][Full Text] [Related]
11. Metabonomic understanding of probiotic effects in humans with irritable bowel syndrome.
Hong YS; Hong KS; Park MH; Ahn YT; Lee JH; Huh CS; Lee J; Kim IK; Hwang GS; Kim JS
J Clin Gastroenterol; 2011; 45(5):415-25. PubMed ID: 21494186
[TBL] [Abstract][Full Text] [Related]
12. Probiotics in the treatment of irritable bowel syndrome.
Saggioro A
J Clin Gastroenterol; 2004 Jul; 38(6 Suppl):S104-6. PubMed ID: 15220671
[TBL] [Abstract][Full Text] [Related]
13. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.
Camilleri M
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S123-5. PubMed ID: 18806702
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of double-coated probiotics for irritable bowel syndrome: a randomized double-blind controlled trial.
Han K; Wang J; Seo JG; Kim H
J Gastroenterol; 2017 Apr; 52(4):432-443. PubMed ID: 27178566
[TBL] [Abstract][Full Text] [Related]
15. [Probiotic supplement (Lactobacillus acidophilus and bulgaricus) utility in the treatment of irritable bowel syndrome].
Diaz Ferrer J; Parra V; Bendaño T; Montes P; Solorzano P
Rev Gastroenterol Peru; 2012; 32(4):387-93. PubMed ID: 23307089
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome.
Sinn DH; Song JH; Kim HJ; Lee JH; Son HJ; Chang DK; Kim YH; Kim JJ; Rhee JC; Rhee PL
Dig Dis Sci; 2008 Oct; 53(10):2714-8. PubMed ID: 18274900
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial.
Begtrup LM; de Muckadell OB; Kjeldsen J; Christensen RD; Jarbøl DE
Scand J Gastroenterol; 2013 Oct; 48(10):1127-35. PubMed ID: 23957590
[TBL] [Abstract][Full Text] [Related]
18. Bifidobacterium bifidum MIMBb75 in irritable bowel syndrome.
Quigley EM
Aliment Pharmacol Ther; 2011 Jul; 34(1):100-1; author reply 101. PubMed ID: 21631550
[No Abstract] [Full Text] [Related]
19. [Clinico-physiological rationale for the use of the mesodiencephalic modulation in combination with synobiotics in the irritable bowel syndrome].
Efendieva MT; Gusakova EV
Vopr Kurortol Fizioter Lech Fiz Kult; 2008; (2):25-8. PubMed ID: 18507185
[No Abstract] [Full Text] [Related]
20. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
Didari T; Mozaffari S; Nikfar S; Abdollahi M
World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
